Research Article
MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis
Table 1
Characteristics of the patients with HCC.
| | Characteristics |
| | Age, year | | | Mean ± SE | 46.9 ± 11.5 | | Range | 15–75 | | Sex | | | Man, n (%) | 189 (91.3) | | Female, n (%) | 18 (8.7) | | Ethnicity | | | Han, n (%) | 163 (78.7) | | Minority, n (%) | 44 (21.3) | | HBV infection | | | HBsAg (−), n (%) | 33 (15.9) | | HBsAg (+), n (%) | 174 (84.1) | | HCV infection | | | anti-HCV (−), n (%) | 204 (98.6) | | anti-HCV (+), n (%) | 3 (1.4) | | Smoking status | | | No, n (%) | 165 (79.7) | | Yes, n (%) | 42 (20.3) | | Drinking status | | | No, n (%) | 167 (80.7) | | Yes, n (%) | 40 (19.3) | | Liver cirrhosis | | | No, n (%) | 41 (19.8) | | Yes, n (%) | 166 (80.2) | | TNM stage | | | I, n (%) | 13 (6.3) | | II, n (%) | 194 (93.7) | | Tumor size | | | ≤5 cm, n (%) | 101 (48.8) | | >5 cm, n (%) | 106 (51.2) | | Tumor grade | | | I | 44 (21.3) | | II | 106 (51.2) | | III | 54 (26.1) | | IV | 3 (1.4) |
| | Total, n (%) | 207 (100) |
|
|
